PHILIP KONG: Open Payments
NPI 1205489929 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 13 payments from 8 companies in 2025. Trend: 2023 $204 · 2024 $294 · 2025 $347
Food & beverage: $248Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $124 |
| Lilly USA, LLC | 4 | $70 |
| ABBVIE INC. | 2 | $40 |
| Alkermes, Inc. | 1 | $28 |
| Organon LLC | 1 | $27 |
| Dexcom, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: TREMFYA, MOUNJARO, VRAYLAR, VIVITROL, NEXPLANON, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit, Qelbree.
Industry payments across GA — which companies pay providers there.
